Sheldon Markowitz, chief of endocrinology at Episcopal Health Services (New York), told HealthCentral: "Even if a GLP-1 patch had true GLP-1 medications, it's not possible to deliver this medication via that route
By addressing potential financial barriers ahead of time, pharmacists can reduce treatment interruptions to prevent further GI complications
How will the oral GLP-1 change demand
Diabetes drugs and stroke risk: intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials
Quarenghi, M., Capelli, S., Galligani, G., Giana, A., Preatoni, G., & Turri Quarenghi, R
CDSCO flags GLP-1 obesity campaigns Compliance requirements The ministry further requires all manufacturers, importers, and marketing authorization holders to ensure strict compliance with the Drugs and Cosmetics Act, 1940 and Rules made thereunder